YMAB Chart
- 52-Week Range: $6.55 - $37.64
- Market Capitalization: $463.85M
- Short Percentage: 0%
- Target Price: $28.17
- Shares Outstanding: 43.72M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
YMAB released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- Y-mAbs Announces Submission of Omburtamab Biologics License Application to FDAGlobeNewsWire | April 1st
- Moore Kuehn, PLLC Encourages Investors of Y-mAbs Therapeutics, Inc. to Contact Law FirmNewsfile Corp | March 17th
- Y-MAbs Therapeutics, Inc. (YMAB) CEO Claus Møller on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha | February 25th
- Y-mAbs Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Corporate DevelopmentsGlobeNewsWire | February 24th
- Y-mAbs Announces Completion of Pre-BLA Meeting with FDA for OmburtamabGlobeNewsWire | February 11th
- Y-mAbs Therapeutics, Inc.'s (YMAB) CEO Claus Moller on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha | November 5th
- Y-mAbs Announces Third Quarter Financial Results and Recent Corporate DevelopmentsGlobeNewsWire | November 4th
- Y-mAbs Announces Priority Review of BLA for DANYELZA® (naxitamab-gqgk) in ChinaGlobeNewsWire | September 13th
- Y-mAbs Therapeutics, Inc. (YMAB) CEO Claus Moller on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha | August 8th
Company Info
Website: https://www.ymabs.com
Address: 230 Park Avenue, New York, NY, United States, 10169
Sector: Healthcare
Industry: Biotechnology
Full time employees: 148
Address: 230 Park Avenue, New York, NY, United States, 10169
Sector: Healthcare
Industry: Biotechnology
Full time employees: 148
$YMAB time will come
$YMAB man this will be good in coming weeks
$YMAB come on I wana jump up and down
$YMAB up we go
$YMAB nice
$YMAB lets go <3
$YMAB Like if you’re a bull
$YMAB we going up from here
$YMAB gonna take my L with this one